Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. (Q55461310)

12 July 2018

title

Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. (English)

1 reference

12 July 2018

0 references

1 reference

Xiangjun Ji

1

1 reference

12 July 2018

Handong Wang

2

1 reference

12 July 2018

Jianhong Zhu

3

1 reference

12 July 2018

Lin Zhu

4

1 reference

12 July 2018

Hao Pan

5

1 reference

12 July 2018

Wei Li

6

1 reference

12 July 2018

Yuan Zhou

7

1 reference

12 July 2018

Zixiang Cong

8

1 reference

12 July 2018

Feng Yan

9

1 reference

12 July 2018

Suihua Chen

10

1 reference

12 July 2018

language of work or name

English

0 references

publication date

10 January 2014

1 reference

12 July 2018

International Journal of Cancer

published in

1 reference

12 July 2018

volume

135

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

574-584

1 reference

12 July 2018

Malignant gliomas in adults

cites work

1 reference

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

21 January 2018

1 reference

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

21 January 2018

1 reference

Regulation of neuronal glutathione synthesis

21 January 2018

1 reference

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

21 January 2018

1 reference

A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo.

21 January 2018

1 reference

The expression of NF-E2-related factor 2 in the rat brain after traumatic brain injury.

21 January 2018

1 reference

Role of Nrf2 in protection against intracerebral hemorrhage injury in mice

21 January 2018

1 reference

Dual roles of Nrf2 in cancer

21 January 2018

1 reference

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

21 January 2018

1 reference

The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer.

21 January 2018

1 reference

Nrf2: friend or foe for chemoprevention?

21 January 2018

1 reference

Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer

21 January 2018

1 reference

Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers

21 January 2018

1 reference

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy

21 January 2018

1 reference

The role of Nrf2 in migration and invasion of human glioma cell U251.

21 January 2018

1 reference

The involvement of Nrf2-ARE pathway in regulation of apoptosis in human glioblastoma cell U251.

21 January 2018

1 reference

NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.

21 January 2018

1 reference

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

21 January 2018

Biology of HIF-1alpha

1 reference

Intratumoral hypoxia, radiation resistance, and HIF-1.

21 January 2018

1 reference

The hypoxic response: huffing and HIFing

21 January 2018

1 reference

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

21 January 2018

1 reference

Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer

21 January 2018

1 reference

GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer

21 January 2018

1 reference

Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis.

21 January 2018

1 reference

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.

21 January 2018

1 reference

Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

21 January 2018

1 reference

Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer

21 January 2018

1 reference

Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer

21 January 2018

1 reference

A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity

21 January 2018

1 reference

Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer

21 January 2018

1 reference

Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer

21 January 2018

1 reference

RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy

21 January 2018

1 reference

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

Hypoxia, gene expression, and metastasis

21 January 2018

1 reference

Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro

21 January 2018

1 reference

Mitochondria and cellular oxygen sensing in the HIF pathway.

21 January 2018

1 reference

Does inhibition of degradation of hypoxia-inducible factor (HIF) alpha always lead to activation of HIF? Lessons learnt from the effect of proteasomal inhibition on HIF activity

21 January 2018

1 reference

Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1α Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1α Protein

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28699

1 reference

12 July 2018

1 reference

12 July 2018